Skip to main content
Industry News
Study: Blinding C. diff panel may hinder diagnoses
2/22/2021

Labs may blind the Clostridium difficile BioFire FilmArray GI Panel due to concerns about over-diagnosis, but that can lead to missed C. diff diagnoses, according to a study led by Ioannis M. Zacharioudakis, MD, of the New York University School of Medicine and published in Diagnostic Microbiology and Infectious Disease. "The practice of concealing C. difficile FilmArray GI Panel results needs to be re-considered in patients presenting with community-onset colitis," researchers wrote.

Full Story: